Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision status updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:16:48.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:19:02.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1, a minor update that does not modify study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T17:51:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated footer/version labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T11:13:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:28:21.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added New York as a study location under Locations and updated the page to revision v3.3.3. The previous 'New York Locations' entry and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T22:32:17.000Z thumbnail image

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.